Plunkett Research Online: GTx Inc

GTX INC (GTXI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

GTx, Inc operates as a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical conditions. It is developing toremifene citra.....



GTx Inc
Ticker: GTXI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 901 523-9700
Fax: 901 523-9772
Address: 175 Toyota Plaza
7th Floor
Memphis, TN 38103 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Hormone Preparations (Except In-Vitro Diagnostics) Manufacturing
ContactsDescription
Marc HanoverCEO/Co-Founder/Director
Jason ShackelfordCFO/Chief Accounting Officer/President, Divisional
See More
GTx, Inc operates as a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical conditions. It is developing toremifene citra.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Cooley LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: